Gowling WLG advised Sosei Heptares.Sosei Heptares signed a collaboration and license agreement with Eli Lilly to develop new treatments in diabetes and metabolic diseases. The deal…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
